Condition: Solid Tumor · Non-Small Cell Lung Cancer · Head and Neck Cancer · Sponsor: Betta Pharmaceuticals Co., Ltd.
This is a multi-center, open-label, Phase I/II clinical study of MCLA-129 as monotherapy in patients with advanced solid tumors to evaluate the safety, pharmacokinetic characteristics and antitumor activity of MCLA-129.
This description comes directly from the study's public registry record.
Wanlin Chen, Master · 18258270120 · wanlin.chen@bettapharma.com
Always discuss trial participation with your own doctor first.
| Affiliated Hospital of Hebei University | Baoding, China | Recruiting |
| Beijing Cancer Hospital | Beijing, China | Recruiting |
| Beijing Friendship Hospital, Capital Medical University | Beijing, China | Recruiting |
| Beijing Tongren Hospital | Beijing, China | Recruiting |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Beijing, China | Recruiting |
| Peking University International Hospital | Beijing, China | Recruiting |
| The Fifth Medical Center of PLA Ceneral Hospital | Beijing, China | Recruiting |
| The First Affiliated Hospital of Bengbu Medical College | Bengbu, China | Recruiting |
| The First Affiliated Hospital of Bengbu Medical University | Bengbu, China | Recruiting |
| Cangzhou Hospital of Integrated TCM-WM·Hebei | Cangzhou, China | Recruiting |
| Ji Lin Cancer Hospital | Changchun, China | Recruiting |
| Hunan Cancer Hospital | Changsha, China | Recruiting |
+ 75 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04930432